Loading...
Loading...
Among the 7 tracked institutional investors we monitor, CNTA (CENTESSA PHARMACEUTICALS PLC) is held with a combined value of $403.86M across 10,167,591 shares. The largest holder is FMR LLC with a position worth $272.16M (0.01% of their portfolio). Point72 Asset Management, L.P. opened a new position in the most recent quarter. 2 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$403.86M
Total Shares Held
10,167,591
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $272.16M | 0.01% | -23.5% |
| 2 | MILLENNIUM MANAGEMENT LLC | $31.42M | 0.01% | -57.7% |
| 3 | CITADEL ADVISORS LLC | $29.00M | 0.00% | +25.9% |
| 4 | BAKER BROS. ADVISORS LP | $26.64M | 0.15% | - |
| 5 | BlackRock, Inc. | $24.84M | 0.00% | +5.5% |
| 6 | Point72 Asset Management, L.P. | $12.44M | 0.02% | New |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $7.35M | 0.01% | -33.8% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of CNTA with a position worth $272.16M, representing 0.01% of their portfolio. In total, 7 institutional investors hold CNTA with a combined value of $403.86M.
In the most recent quarter, 1 fund opened a new position in CNTA. Additionally, 2 increased their holdings and 3 reduced their positions.
Institutional investors hold $403.86M worth of CNTA stock across 7 positions. The largest institutional holder is FMR LLC with $272.16M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CNTA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CNTA positions.